Physical function, disease activity, and health-related quality-of-life outcomes after 3 years of adalimumab treatment in patients with ankylosing spondylitis

INTRODUCTION: We evaluated the three-year impact of adalimumab on patient-reported physical function and health-related quality-of-life (HRQOL) outcomes in patients with active ankylosing spondylitis (AS). METHODS: The Adalimumab Trial Evaluating Long-Term Efficacy and Safety in AS (ATLAS) is an ong...

Descripción completa

Detalles Bibliográficos
Autores principales: van der Heijde, Désirée M, Revicki, Dennis A, Gooch, Katherine L, Wong, Robert L, Kupper, Hartmut, Harnam, Neesha, Thompson, Chris, Sieper, Joachim
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2745808/
https://www.ncbi.nlm.nih.gov/pubmed/19686597
http://dx.doi.org/10.1186/ar2790

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2745808/
https://www.ncbi.nlm.nih.gov/pubmed/19686597
http://dx.doi.org/10.1186/ar2790

Ejemplares similares